{"ai_pass_count":4,"analysis_step_count":9,"confidence":0.8190284790471196,"created_at":"2026-08-09T02:28:31.301223+00:00","id":217400,"node_number":"683210","processing_time":1.6822569370269775,"recent_steps":["net.store_session","net.llm_structured_analysis","net.rules_detect","net.context_window","crawler.extract_candidates"],"recording_id":227708,"text":"the human cell and the same one targeted by conventional flu shot. And HA, or hemocleutinum, mutates fairly quick, which makes it a challenge for conventional vaccine to match the flu virus. So 40,000 people participated in the study where 970 became male from the flu. The mRNA vaccine was 26.6% more protective of the potential vaccine against illness from the flu. And EM Puseva gave superior protection against each of the three flu subtypes included in the vaccine. And participants 65 and up received 27.4% more protection overall, dropping. And the mRNA group developed more to the flu."}